As part of our coverage of the European Society for Medical Oncology (ESMO) 2017 Congress, we spoke with Claire Vale, PhD, a senior research scientist within the MRC Clinical Trials Unit and a member of the faculty of population health sciences at University College London in the United Kingdom. Dr. Vale presented a late-breaking abstract on a meta-analysis of optimal systemic therapy options for men with metastatic hormone-sensitive prostate cancer. Read more